SEARCH

SEARCH BY CITATION

References

  • 1
    Centers for Disease Control and Prevention (CDC). Cancer survivors–United States, 2007. MMWR Morb Mortal Wkly Rep. 2011; 60: 269-272.
  • 2
    Howlader N, Noone A, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011.
  • 3
    Jones LW, Demark-Wahnefried W. Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol. 2006; 7: 1017-1026.
  • 4
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29.
  • 5
    Doyle C, Kushi LH, Byers T, et al; 2006 Nutrition, Physical Activity and Cancer Survivorship Advisory Committee; American Cancer Society. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2006; 56: 323-353.
  • 6
    Jones LW, Courneya KS, Fairey AS, Mackey JR. Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med. 2004; 28: 105-113.
  • 7
    Pekmezi DW, Demark-Wahnefried W. Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol. 2011; 50: 167-178.
  • 8
    Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002; 20: 1128-1143.
  • 9
    Schattner M, Shike M. Nutrition support of the patient with cancer. In: Shils ME, Shike M, Ross AC, Cabellero B, Cousins RJ, eds. Modern Nutrition in Health and Disease. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006: 1290-1313.
  • 10
    Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12: 489-495.
  • 11
    Blum D, Omlin A, Baracos VE, et al; European Palliative Care Research Collaborative. Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol. 2011; 80: 114-144.
  • 12
    McMahon K, Brown JK. Nutritional screening and assessment. Semin Oncol Nurs. 2000; 16: 106-112.
  • 13
    Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol. 2005; 23: 1431-1438.
  • 14
    Rock CL. Dietary counseling is beneficial for the patient with cancer. J Clin Oncol. 2005; 23: 1348-1349.
  • 15
    McGough C, Baldwin C, Frost G, Andreyev HJ. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer. 2004; 90: 2278-2287.
  • 16
    Ornish D, Weidner G, Fair WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005; 174: 1065-1069; discussion 1069-1070.
  • 17
    Monsen ER. Dietary Reference Intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J Am Diet Assoc. 2000; 100: 637-640.
  • 18
    National Research Council. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2010.
  • 19
    Panel on Macronutrients, Panel on the Definition of Dietary Fiber, Subcommittee on Upper Reference Levels of Nutrients, Subcommittee on Interpretation and Uses of Dietary Reference Intakes, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: The National Academies Press; 2002.
  • 20
    National Research Council. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Panothenic Acid, Biotin, and Choline. Washington, DC: The National Academies Press; 1998.
  • 21
    National Research Council. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: The National Academies Press; 2000.
  • 22
    Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 2008; 100: 773-783.
  • 23
    Prasad KN, Kumar A, Kochupillai V, Cole WC. High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr. 1999; 18: 13-25.
  • 24
    Greenlee H, White E, Patterson RE, Kristal AR; Vitamins and Lifestyle (VITAL) Study Cohort. Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med. 2004; 10: 660-666.
  • 25
    Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS, Ballard-Barbash R. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc. 2008; 108: 483-494.
  • 26
    Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010; 28: 340-347.
  • 27
    Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2010; 4: 87-100.
  • 28
    Schmitz KH, Courneya KS, Matthews C, et al; American College of Sports Medicine. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010; 42: 1409-1426.
  • 29
    Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007; 25: 4396-4404.
  • 30
    Courneya KS, Sellar CM, Stevinson C, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009; 27: 4605-4612.
  • 31
    Jones LW, Eves ND, Courneya KS, et al. Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts. Clin Cancer Res. 2005; 11: 6695-6698.
  • 32
    Dahn JR, Penedo FJ, Molton I, Lopez L, Schneiderman N, Antoni MH. Physical activity and sexual functioning after radiotherapy for prostate cancer: beneficial effects for patients undergoing external beam radiotherapy. Urology. 2005; 65: 953-958.
  • 33
    Winters-Stone KM, Dobek J, Nail L, et al. Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat. 2011; 127: 447-456.
  • 34
    Schwartz AL, Winters-Stone K. Effects of a 12-month randomized controlled trial of aerobic or resistance exercise during and following cancer treatment in women. Phys Sportsmed. 2009; 37: 62-67.
  • 35
    Mutrie N, Campbell AM, Whyte F, et al. Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ. 2007; 334: 517.
  • 36
    Dolan LB, Gelmon K, Courneya KS, et al. Hemoglobin and aerobic fitness changes with supervised exercise training in breast cancer patients receiving chemotherapy. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2826-2832.
  • 37
    Sunga AY, Eberl MM, Oeffinger KC, Hudson MM, Mahoney MC. Care of cancer survivors. Am Fam Physician. 2005; 71: 699-706.
  • 38
    Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin. 2004; 54: 208-236.
  • 39
    Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011; 50: 187-193.
  • 40
    Grosvenor M, Bulcavage L, Chlebowski RT. Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration. Cancer. 1989; 63: 330-334.
  • 41
    Deitel M, To TB. Major intestinal complications of radiotherapy. Management and nutrition. Arch Surg. 1987; 122: 1421-1424.
  • 42
    Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996; 12( suppl 1): S15-S19.
  • 43
    Von Roenn J. Pharmacologic interventions for cancer-related weight loss. Oncology Issues. 2002; 17: 18-21.
  • 44
    Coward DD. Supporting health promotion in adults with cancer. Fam Community Health. 2006; 29( suppl 1): 52S-60S.
  • 45
    Ng AK, Travis LB. Second primary cancers: an overview. Hematol Oncol Clin North Am. 2008; 22: 271-289, vii.
  • 46
    US Department of Agriculture and US Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th ed. Washington, DC: US Government Printing Office; 2010.
  • 47
    World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR; 2007.
  • 48
    World Health Organization/Food and Agriculture Organization of the United Nations. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. Technical Report Series 916. Geneva, Switzerland: World Health Organization; 2003.
  • 49
    American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006; 114: 82-96.
  • 50
    August DA. Nutrition and cancer: where are we going? Top Clin Nutr. 2003; 18: 268-279.
  • 51
    Eyre H, Kahn R, Robertson RM; ACS/ADA/AHA Collaborative Writing Committee. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. CA Cancer J Clin. 2004; 54: 190-207.
  • 52
    Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012; 62: 30-67.
  • 53
    Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010; 123: 627-635.
  • 54
    Patterson RE, Cadmus LA, Emond JA, Pierce JP. Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas. 2010; 66: 5-15.
  • 55
    Vanio H, Bianchini F. IARC Handbooks of Cancer Prevention. Vol 6. Weight Control and Physical Activity. Lyon, France: International Agency for Research on Cancer; 2002.
  • 56
    Freedland SJ, Grubb KA, Yiu SK, et al. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. J Urol. 2005; 174: 919-922.
  • 57
    Amling CL. The association between obesity and the progression of prostate and renal cell carcinoma. Urol Oncol. 2004; 22: 478-484.
  • 58
    Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M. Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer. 2010; 18: 433-437.
  • 59
    Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA. Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol. 2006; 59: 704-709.
  • 60
    Hopkinson JB, Wright DN, Foster C. Management of weight loss and anorexia. Ann Oncol. 2008; 19( suppl 7): vii289-vii293.
  • 61
    Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer. 2004; 12: 246-252.
  • 62
    Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011; 28: 753-765.
  • 63
    Meyerhardt JA, Ma J, Courneya KS. Energetics in colorectal and prostate cancer. J Clin Oncol. 2010; 28: 4066-4073.
  • 64
    Moorman PG, Jones LW, Akushevich L, Schildkraut JM. Recreational physical activity and ovarian cancer risk and survival. Ann Epidemiol. 2011; 21: 178-187.
  • 65
    Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011; 29: 726-732.
  • 66
    National Comprehensive Cancer Network. NCCN Palliative Care Guidelines. Fort Washington, PA: National Comprehensive Cancer Network; 2011. http://www.nccn. org/professionals/physician_gls/pdf/pallia tive.pdf. [Access to NCCN guidelines is restricted to members.]
  • 67
    August DA, Huhmann MB; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2009; 33: 472-500.
  • 68
    Mirtallo J, Canada T, Johnson D, et al; Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004; 28: S39-S70.
  • 69
    American Dietetic Association. Ethical and legal issues in nutrition, hydration and feeding. J Am Diet Assoc. 2008; 108: 873-882.
  • 70
    Lowe SS, Watanabe SM, Courneya KS. Physical activity as a supportive care intervention in palliative cancer patients: a systematic review. J Support Oncol. 2009; 7: 27-34.
  • 71
    Beaton R, Pagdin-Friesen W, Robertson C, Vigar C, Watson H, Harris SR. Effects of exercise intervention on persons with metastatic cancer: a systematic review. Physiother Can. 2009; 61: 141-153.
  • 72
    Centers for Disease Control and Prevention. Overweight and Obesity. Atlanta, GA: Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/obesity/. Accessed March 23, 2012.
  • 73
    Norat T, Chan D, Lau R, Vieira R. The Associations Between Food, Nutrition and Physical Activity and the Risk of Breast Cancer. World Cancer Research Fund/American Institute for Cancer Research Systematic Literature Review Continuous Update Project Report. London: World Cancer Research Fund/American Institute for Cancer Research; 2008.
  • 74
    Norat T, Chan D, Lau R, Aune D, Vieira R. The Associations Between Food, Nutrition and Physical Activity and the Risk of Colorectal Cancer. London: World Cancer Research Fund/American Institute for Cancer Research; 2010.
  • 75
    Aune D, Greenwood DC, Chan DS, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies [published online ahead of print October 3, 2011]. Ann Oncol.
  • 76
    McTiernan A, Irwin M, Vongruenigen V. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol. 2010; 28: 4074-4080.
  • 77
    Wright ME, Chang SC, Schatzkin A, et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer. 2007; 109: 675-684.
  • 78
    Vrieling A, Kampman E. The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr. 2010; 92: 471-490.
  • 79
    Irwin ML, Mayne ST. Impact of nutrition and exercise on cancer survival. Cancer J. 2008; 14: 435-441.
  • 80
    Siegel EM, Ulrich CM, Poole EM, Holmes RS, Jacobsen PB, Shibata D. The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control. 2010; 17: 52-57.
  • 81
    Efstathiou JA, Bae K, Shipley WU, et al. Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31. Cancer. 2007; 110: 2691-2699.
  • 82
    Vance V, Mourtzakis M, McCargar L, Hanning R. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev. 2011; 12: 282-294.
  • 83
    Jiang W, Zhu Z, Thompson HJ. Effects of physical activity and restricted energy intake on chemically induced mammary carcinogenesis. Cancer Prev Res (Phila). 2009; 2: 338-344.
  • 84
    Pollak M. Do cancer cells care if their host is hungry? Cell Metab. 2009; 9: 401-403.
  • 85
    Vona-Davis L, Rose DP. Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev. 2009; 20: 193-201.
  • 86
    Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005; 23: 1370-1378.
  • 87
    Nichols HB, Trentham-Dietz A, Egan KM, et al. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1403-1409.
  • 88
    Thivat E, Therondel S, Lapirot O, et al. Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer. 2010; 10: 648.
  • 89
    Meyerhardt JA, Niedzwiecki D, Hollis D, et al; Cancer and Leukemia Group B 89803. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol. 2008; 26: 4109-4115.
  • 90
    Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010; 170: 1566-1575.
  • 91
    Chlebowski RT, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst. 2006; 98: 1767-1776.
  • 92
    Miller ME, Kral JG. Surgery for obesity in older women. Menopause Int. 2008; 14: 155-162.
  • 93
    Jen KL, Djuric Z, DiLaura NM, et al. Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens. Obes Res. 2004; 12: 306-312.
  • 94
    Ligibel JA, Campbell N, Partridge A, et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol. 2008; 26: 907-912.
  • 95
    Morey MC, Snyder DC, Sloane R, et al. Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA. 2009; 301: 1883-1891.
  • 96
    Demark-Wahnefried W, Case LD, Blackwell K, et al. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer. 2008; 8: 70-79.
  • 97
    Seagle HM, Strain GW, Makris A, Reeves RS, American Dietetic Association. Position of the American Dietetic Association: weight management. J Am Diet Assoc. 2009; 109: 330-346.
  • 98
    Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol. 2002; 20: 3302-3316.
  • 99
    Centers for Disease Control and Prevention. Healthy Weight–it's not a diet, it's a lifestyle! Atlanta, GA: Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/healthyweight/losing_weight/index.html. Accessed February 12, 2012.
  • 100
    National Heart, Lung, and Blood Institute. Aim for a Healthy Weight! Bethesda, MD: National Heart, Lung, and Blood Institute; 2011. http://www.nhlbi.nih.gov/health/public/heart/obesity/lose_wt/index.htm. Accessed February 26, 2012.
  • 101
    Smith JL, Malinauskas BM, Garner KJ, Barber-Heidal K. Factors contributing to weight loss, nutrition-related concerns and advice received by adults undergoing cancer treatment. Adv Med Sci. 2008; 53: 198-204.
  • 102
    Courneya KS. Exercise in cancer survivors: an overview of research. Med Sci Sports Exerc. 2003; 35: 1846-1852.
  • 103
    Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005; 293: 2479-2486.
  • 104
    Meyerhardt JA, Giovannucci EL, Ogino S, et al. Physical activity and male colorectal cancer survival. Arch Intern Med. 2009; 169: 2102-2108.
  • 105
    Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006; 24: 3535-3541.
  • 106
    Meyerhardt JA, Giovannucci EL, Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006; 24: 3527-3534.
  • 107
    Haydon AM, Macinnis RJ, English DR, Giles GG. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006; 55: 62-67.
  • 108
    Courneya KS, Booth CM, Gill S, et al. The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Curr Oncol. 2008; 15: 279-285.
  • 109
    Ferrer RA, Huedo-Medina TB, Johnson BT, Ryan S, Pescatello LS. Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes. Ann Behav Med. 2011; 41: 32-47.
  • 110
    Brown JC, Huedo-Medina TB, Pescatello LS, Pescatello SM, Ferrer RA, Johnson BT. Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011; 20: 123-133.
  • 111
    Schmitz KH, Ahmed RL, Troxel A, et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 2009; 361: 664-673.
  • 112
    Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010; 304: 2699-2705.
  • 113
    US Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services; 1996.
  • 114
    US Department of Health and Human Services. Physical Activity Guidelines for Americans. Washington, DC: US Department of Health and Human Services; 2008.
  • 115
    Courneya K, Karvinen K, Vallance JK. Exercise motivation and behavior change. In: Feuerstein M, ed. Handbook of Cancer Survivorship. New York: Springer Science-Business Media LLC; 2007: 113-132.
  • 116
    Pinto BM, Ciccolo JT. Physical activity motivation and cancer survivorship. Recent Results Cancer Res. 2011; 186: 367-387.
  • 117
    White SM, McAuley E, Estabrooks PA, Courneya KS. Translating physical activity interventions for breast cancer survivors into practice: an evaluation of randomized controlled trials. Ann Behav Med. 2009; 37: 10-19.
  • 118
    US Department of Health and Human Services. Be Active Your Way: A Fact Sheet for Adults. Washington, DC: US Department of Health and Human Services; 2008. http://www.health.gov/PAGuidelines/factSheetAdults.aspx. Accessed February 21, 2012.
  • 119
    Norman SA, Potashnik SL, Galantino ML, De Michele AM, House L, Localio AR. Modifiable risk factors for breast cancer recurrence: what can we tell survivors? J Womens Health (Larchmt). 2007; 16: 177-190.
  • 120
    Kroenke CH, Fung TT, Hu FB, Holmes MD. Dietary patterns and survival after breast cancer diagnosis. J Clin Oncol. 2005; 23: 9295-9303.
  • 121
    Kwan ML, Weltzien E, Kushi LH, Castillo A, Slattery ML, Caan BJ. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009; 27: 919-926.
  • 122
    Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007; 298: 289-298.
  • 123
    Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007; 298: 754-764.
  • 124
    National Research Council. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: The National Academies Press; 2002.
  • 125
    McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer. 2006; 55: 132-140.
  • 126
    Beasley JM, Newcomb PA, Trentham-Dietz A, et al. Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat. 2011; 128: 229-236.
  • 127
    Goodwin PJ, Ennis M, Pritchard KI, Koo J, Trudeau ME, Hood N. Diet and breast cancer: evidence that extremes in diet are associated with poor survival. J Clin Oncol. 2003; 21: 2500-2507.
  • 128
    Gold EB, Pierce JP, Natarajan L, et al. Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol. 2009; 27: 352-359.
  • 129
    Kim DJ, Gallagher RP, Hislop TG, et al. Premorbid diet in relation to survival from prostate cancer (Canada). Cancer Causes Control. 2000; 11: 65-77.
  • 130
    Fradet Y, Meyer F, Bairati I, Shadmani R, Moore L. Dietary fat and prostate cancer progression and survival. Eur Urol. 1999; 35: 388-391.
  • 131
    Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998; 82: 395-402.
  • 132
    Hardman WE. (n-3) fatty acids and cancer therapy. J Nutr. 2004; 134( suppl 12): 3427S-3430S.
  • 133
    MacLean CH, Newberry SJ, Mojica WA, et al. Effects of Omega-3 Fatty Acids on Cancer. Summary. Evidence Report/Technology Assessment No. 113; AHRQ Pub. No. 05-E010-2. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
  • 134
    Slavin J. Why whole grains are protective: biological mechanisms. Proc Nutr Soc. 2003; 62: 129-134.
  • 135
    Tohill BC, Seymour J, Serdula M, Kettel-Khan L, Rolls BJ. What epidemiologic studies tell us about the relationship between fruit and vegetable consumption and body weight. Nutr Rev. 2004; 62: 365-374.
  • 136
    Rock CL. Diet and breast cancer: can dietary factors influence survival? J Mammary Gland Biol Neoplasia. 2003; 8: 119-132.
  • 137
    Rock CL, Natarajan L, Pu M, et al; Women's Healthy Eating and Living Study Group. Longitudinal biological exposure to carotenoids is associated with breast cancer-free survival in the Women's Healthy Eating and Living Study. Cancer Epidemiol Biomarkers Prev. 2009; 18: 486-494.
  • 138
    Thomson CA, Alberts DS. Diet and survival after ovarian cancer: where are we and what's next? J Am Diet Assoc. 2010; 110: 366-368.
  • 139
    Dolecek TA, McCarthy BJ, Joslin CE, et al. Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer. J Am Diet Assoc. 2010; 110: 369-382.
  • 140
    Nagle CM, Purdie DM, Webb PM, Green A, Harvey PW, Bain CJ. Dietary influences on survival after ovarian cancer. Int J Cancer. 2003; 106: 264-269.
  • 141
    Chan JM, Holick CN, Leitzmann MF, et al. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control. 2006; 17: 199-208.
  • 142
    Gahche J, Bailey R, Burt V, et al. Dietary Supplement Use Among US Adults Has Increased Since NHANES III (1988-1994). NCHS Data Brief, No. 61. Hyattsville, MD: National Center for Health Statistics; 2011.
  • 143
    Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008; 26: 665-673.
  • 144
    Reedy J, Haines PS, Steckler A, Campbell MK. Qualitative comparison of dietary choices and dietary supplement use among older adults with and without a history of colorectal cancer. J Nutr Educ Behav. 2005; 37: 252-258.
  • 145
    Yates JS, Mustian KM, Morrow GR, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005; 13: 806-811.
  • 146
    Davies AA, Davey Smith G, Harbord R, et al. Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review. J Natl Cancer Inst. 2006; 98: 961-973.
  • 147
    Pocobelli G, Peters U, Kristal AR, White E. Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality. Am J Epidemiol. 2009; 170: 472-483.
  • 148
    Saquib J, Rock CL, Natarajan L, et al. Dietary intake, supplement use, and survival among women diagnosed with early-stage breast cancer. Nutr Cancer. 2011; 63: 327-333.
  • 149
    Kwan ML, Greenlee H, Lee VS, et al. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011; 130: 195-205.
  • 150
    Ng K, Meyerhardt JA, Chan JA, et al. Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2010; 28: 4354-4363.
  • 151
    Baron JA, Cole BF, Mott L, et al. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst. 2003; 95: 717-722.
  • 152
    Bairati I, Meyer F, Jobin E, et al. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer. 2006; 119: 2221-2224.
  • 153
    Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011; 306: 1549-1556.
  • 154
    Neuhouser ML, Sorensen B, Hollis BW, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr. 2008; 88: 133-139.
  • 155
    Jacobs ET, Thomson CA, Flatt SW, et al. Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr. 2011; 93: 108-117.
  • 156
    Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008; 26: 2984-2991.
  • 157
    Ng K, Wolpin BM, Meyerhardt JA, et al. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009; 101: 916-923.
  • 158
    Buttigliero C, Monagheddu C, Petroni P, et al. Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. Oncologist. 2011; 16: 1215-1227.
  • 159
    Lawson KA, Wright ME, Subar A, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst. 2007; 99: 754-764.
  • 160
    Chan AL, Leung HW, Wang SF. Multivitamin supplement use and risk of breast cancer: a meta-analysis. Ann Pharmacother. 2011; 45: 476-484.
  • 161
    Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Multivitamin use and the risk of mortality and cancer incidence: the multiethnic cohort study. Am J Epidemiol. 2011; 173: 906-914.
  • 162
    Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007; 297: 842-857.
  • 163
    Hewitt M, Greenfield S, Stovall E, eds. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: Committee on Cancer Survivorship: Improving Care and Quality of Life, National Cancer Policy Board, Institute of Medicine, and National Research Council of the National Academies: The National Academies Press; 2006.
  • 164
    Monti DA, Yang J. Complementary medicine in chronic cancer care. Semin Oncol. 2005; 32: 225-231.
  • 165
    Colditz GA, DeJong W, Hunter DJ, Trichopoulos D, Willett WC. Harvard Report on Cancer Prevention. Vol 1. Causes of Human Cancer. Cancer Causes Control. 1996; 7( suppl): S3-59.
  • 166
    Rimm E. Alcohol and cardiovascular disease. Curr Atheroscler Rep. 2000; 2: 529-535.
  • 167
    O'Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol. 2007; 50: 1009-1014.
  • 168
    Barrera S, Demark-Wahnefried W. Nutrition during and after cancer therapy. Oncology (Williston Park). 2009; 23( 2 suppl Nurse Ed): 15-21.
  • 169
    Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005; 23: 8884-8893.
  • 170
    Smith-Warner SA, Spiegelman D, Yaun SS, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998; 279: 535-540.
  • 171
    Nielsen SF, Nordestgaard BG, Bojesen SE. Associations between first and second primary cancers: a population-based study. CMAJ. 2012; 184: E57-E69.
  • 172
    Fortin A, Wang CS, Vigneault E. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2009; 74: 1062-1069.
  • 173
    Reding KW, Daling JR, Doody DR, O'Brien CA, Porter PL, Malone KE. Effect of prediagnostic alcohol consumption on survival after breast cancer in young women. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1988-1996.
  • 174
    Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM. Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat. 2007; 105: 195-207.
  • 175
    Flatt SW, Thomson CA, Gold EB, et al. Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol Biomarkers Prev. 2010; 19: 681-688.
  • 176
    Kwan ML, Kushi LH, Weltzien E, et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010; 28: 4410-4416.
  • 177
    Li CI, Daling JR, Porter PL, Tang MT, Malone KE. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. J Clin Oncol. 2009; 27: 5312-5318.
  • 178
    Moe G. Low-microbial diets for patients with granulocytopenia. In: Bloch AS, ed. Nutrition Management of the Cancer Patient. Rockville, MD: Aspen Publishers; 1990: 125.
  • 179
    Carmichael AR, Bates T. Obesity and breast cancer: a review of the literature. Breast. 2004; 13: 85-92.
  • 180
    Loi S, Milne RL, Friedlander ML, et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1686-1691.
  • 181
    Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev. 2004; 5: 153-165.
  • 182
    Enger SM, Bernstein L. Exercise activity, body size and premenopausal breast cancer survival. Br J Cancer. 2004; 90: 2138-2141.
  • 183
    Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr Cancer. 2003; 45: 1-16.
  • 184
    Healy LA, Ryan AM, Carroll P, et al. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol). 2010; 22: 281-288.
  • 185
    Caan BJ, Kwan ML, Hartzell G, et al. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008; 19: 1319-1328.
  • 186
    Paskett ED. Breast cancer-related lymphedema: attention to a significant problem resulting from cancer diagnosis. J Clin Oncol. 2008; 26: 5666-5667.
  • 187
    Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML. Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control. 2005; 16: 545-556.
  • 188
    Herman DR, Ganz PA, Petersen L, Greendale GA. Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study (CAMS). Breast Cancer Res Treat. 2005; 93: 13-23.
  • 189
    Harvie MN, Campbell IT, Baildam A, Howell A. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat. 2004; 83: 201-210.
  • 190
    Caan BJ, Emond JA, Natarajan L, et al. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006; 99: 47-57.
  • 191
    Marinho LA, Rettori O, Vieira-Matos AN. Body weight loss as an indicator of breast cancer recurrence. Acta Oncol. 2001; 40: 832-837.
  • 192
    McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Williston Park). 2005; 19: 871-881.
  • 193
    Aslani A, Smith RC, Allen BJ, Pavlakis N, Levi JA. Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res Treat. 1999; 57: 285-290.
  • 194
    Cheney CL, Mahloch J, Freeny P. Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr. 1997; 66: 141-146.
  • 195
    Demark-Wahnefried W, Hars V, Conaway MR, et al. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr. 1997; 65: 1495-1501.
  • 196
    Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001; 19: 2381-2389.
  • 197
    Harvie MN, Howell A, Thatcher N, Baildam A, Campbell I. Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy–a longitudinal study. Br J Cancer. 2005; 92: 673-680.
  • 198
    Freedman RJ, Aziz N, Albanes D, et al. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab. 2004; 89: 2248-2253.
  • 199
    Schmitz KH, Ahmed RL, Hannan PJ, Yee D. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1672-1680.
  • 200
    Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk? Diabetes Obes Metab. 2011; 13: 1063-1072.
  • 201
    McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006; 175: 34-41.
  • 202
    Smith-Warner SA, Spiegelman D, Adami HO, et al. Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer. 2001; 92: 767-774.
  • 203
    Kushi L, Giovannucci E. Dietary fat and cancer. Am J Med. 2002; 113( suppl 9B): 63S-70S.
  • 204
    Gandini S, Merzenich H, Robertson C, Boyle P. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer. 2000; 36: 636-646.
  • 205
    Smith-Warner SA, Spiegelman D, Yaun SS, et al. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA. 2001; 285: 769-776.
  • 206
    Pierce JP, Newman VA, Flatt SW, et al; Women's Healthy Eating and Living (WHEL) Study Group. Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors. J Nutr. 2004; 134: 452-458.
  • 207
    Rock CL, Flatt SW, Laughlin GA, et al; Women's Healthy Eating and Living Study Group. Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17: 614-620.
  • 208
    Caan BJ, Natarajan L, Parker B, et al. Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev. 2011; 20: 854-858.
  • 209
    Shu XO, Zheng Y, Cai H, et al. Soy food intake and breast cancer survival. JAMA. 2009; 302: 2437-2443.
  • 210
    Guha N, Kwan ML, Quesenberry CP Jr, Weltzien EK, Castillo AL, Caan BJ. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2009; 118: 395-405.
  • 211
    Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst. 1993; 85: 979-987.
  • 212
    Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006; 295: 655-666.
  • 213
    Giovannucci E. Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health (Larchmt). 2003; 12: 173-182.
  • 214
    Ryan-Harshman M, Aldoori W. Diet and colorectal cancer: review of the evidence. Can Fam Physician. 2007; 53: 1913-1920.
  • 215
    Blanchard CM, Courneya KS, Stein K; American Cancer Society's SCS II. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol. 2008; 26: 2198-2204.
  • 216
    Courneya KS, Friedenreich CM. Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. J Altern Complement Med. 1997; 3: 215-226.
  • 217
    Courneya KS, Friedenreich CM. Physical exercise and quality of life following cancer diagnosis: a literature review. Ann Behav Med. 1999; 21: 171-179.
  • 218
    Johnson BL, Trentham-Dietz A, Koltyn KF, Colbert LH. Physical activity and function in older, long-term colorectal cancer survivors. Cancer Causes Control. 2009; 20: 775-784.
  • 219
    Lynch BM, Cerin E, Owen N, Aitken JF. Associations of leisure-time physical activity with quality of life in a large, population-based sample of colorectal cancer survivors. Cancer Causes Control. 2007; 18: 735-742.
  • 220
    Peddle CJ, Au HJ, Courneya KS. Associations between exercise, quality of life, and fatigue in colorectal cancer survivors. Dis Colon Rectum. 2008; 51: 1242-1248.
  • 221
    Courneya KS, Friedenreich CM, Quinney HA, Fields AL, Jones LW, Fairey AS. A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur J Cancer Care (Engl). 2003; 12: 347-357.
  • 222
    Haydon AM, Macinnis RJ, English DR, Morris H, Giles GG. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer. Gut. 2006; 55: 689-694.
  • 223
    Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003; 98: 484-495.
  • 224
    Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol. 2004; 22: 648-657.
  • 225
    Dignam JJ, Polite BN, Yothers G, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006; 98: 1647-1654.
  • 226
    Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol. 2012; 30: 42-52.
  • 227
    Giovannucci E. Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res. 2007; 22( suppl 2): V81-V85.
  • 228
    Byers T. What can randomized controlled trials tell us about nutrition and cancer prevention? CA Cancer J Clin. 1999; 49: 353-361.
  • 229
    Figueiredo JC, Mott LA, Giovannucci E, et al. Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer. 2011; 129: 192-203.
  • 230
    Cole BF, Baron JA, Sandler RS, et al; Polyp Prevention Study Group. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007; 297: 2351-2359.
  • 231
    Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999; 340: 101-107.
  • 232
    DeVita VT, Hellman S, Rosenberg SA. Cancer: Principles & Practice of Oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2001.
  • 233
    Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009; 114: 121-127.
  • 234
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348: 1625-1638.
  • 235
    von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer. 2006; 107: 2786-2791.
  • 236
    Anderson B, Connor JP, Andrews JI, et al. Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol. 1996; 174: 1171-1178; discussion 1178-1179.
  • 237
    Munstedt K, Wagner M, Kullmer U, Hackethal A, Franke FE. Influence of body mass index on prognosis in gynecological malignancies. Cancer Causes Control. 2008; 19: 909-916.
  • 238
    Jeong NH, Lee JM, Lee JK, et al. Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol. 2010; 118: 24-28.
  • 239
    Gates EJ, Hirschfield L, Matthews RP, Yap OW. Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium. J Natl Med Assoc. 2006; 98: 1814-1822.
  • 240
    Basen-Engquist K, Scruggs S, Jhingran A, et al. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol. 2009; 200: 288.e1-288.e8.
  • 241
    Courneya KS, Karvinen KH, Campbell KL, et al. Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol Oncol. 2005; 97: 422-430.
  • 242
    Bandera EV, Kushi LH, Rodriguez-Rodriguez L. Nutritional factors in ovarian cancer survival. Nutr Cancer. 2009; 61: 580-586.
  • 243
    Zhang M, Lee AH, Binns CW, Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer. 2004; 112: 465-469.
  • 244
    Yang L, Klint A, Lambe M, et al. Predictors of ovarian cancer survival: a population-based prospective study in Sweden. Int J Cancer. 2008; 123: 672-679.
  • 245
    Stevinson C, Capstick V, Schepansky A, et al. Physical activity preferences of ovarian cancer survivors. Psychooncology. 2009; 18: 422-428.
  • 246
    Modesitt SC, van Nagell JR Jr. The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv. 2005; 60: 683-692.
  • 247
    Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D; Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007; 335: 1134.
  • 248
    Hess LM, Barakat R, Tian C, Ozols RF, Alberts DS. Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2007; 107: 260-265.
  • 249
    Meloni G, Proia A, Capria S, et al. Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant. 2001; 28: 365-367.
  • 250
    Liu RD, Chinapaw MJ, Huijgens PC, van Mechelen W. Physical exercise interventions in haematological cancer patients, feasible to conduct but effectiveness to be established: a systematic literature review. Cancer Treat Rev. 2009; 35: 185-192.
  • 251
    Wolin KY, Ruiz JR, Tuchman H, Lucia A. Exercise in adult and pediatric hematological cancer survivors: an intervention review. Leukemia. 2010; 24: 1113-1120.
  • 252
    Weisdorf SA, Lysne J, Wind D, et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation. 1987; 43: 833-838.
  • 253
    Lenssen P, Sherry ME, Cheney CL, et al. Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc. 1990; 90: 835-842.
  • 254
    Rowe JM, Ciobanu N, Ascensao J, et al. Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG). Ann Intern Med. 1994; 120: 143-158.
  • 255
    Lipkin AC, Lenssen P, Dickson BJ. Nutrition issues in hematopoietic stem cell transplantation: state of the art. Nutr Clin Pract. 2005; 20: 423-439.
  • 256
    Murray SM, Pindoria S. Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev. 2002;( 2): CD002920.
  • 257
    Brown JK. A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncol Nurs Forum. 2002; 29: 517-532.
  • 258
    Granger CL, McDonald CF, Berney S, Chao C, Denehy L. Exercise intervention to improve exercise capacity and health related quality of life for patients with non-small cell lung cancer: a systematic review. Lung Cancer. 2011; 72: 139-153.
  • 259
    Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996; 276: 1957-1963.
  • 260
    Zhou W, Heist RS, Liu G, et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol. 2007; 25: 479-485.
  • 261
    Sun AS, Ostadal O, Ryznar V, et al. Phase I/II study of stage III and IV non-small cell lung cancer patients taking a specific dietary supplement. Nutr Cancer. 1999; 34: 62-69.
  • 262
    Sun AS, Yeh HC, Wang LH, et al. Pilot study of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV non-small cell lung cancer patients. Nutr Cancer. 2001; 39: 85-95.
  • 263
    Evans WK, Nixon DW, Daly JM, et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol. 1987; 5: 113-124.
  • 264
    Ovesen L, Allingstrup L, Hannibal J, Mortensen EL, Hansen OP. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol. 1993; 11: 2043-2049.
  • 265
    Ovesen L, Allingstrup L. Different quantities of two commercial liquid diets consumed by weight-losing cancer patients. JPEN J Parenter Enteral Nutr. 1992; 16: 275-278.
  • 266
    Kolonel LN, Nomura AM, Cooney RV. Dietary fat and prostate cancer: current status. J Natl Cancer Inst. 1999; 91: 414-428.
  • 267
    Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst. 2000; 92: 61-68.
  • 268
    Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev. 2007; 29: 88-97.
  • 269
    Meyer F, Bairati I, Shadmani R, Fradet Y, Moore L. Dietary fat and prostate cancer survival. Cancer Causes Control. 1999; 10: 245-251.
  • 270
    Heymach JV, Shackleford TJ, Tran HT, et al. Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer. Cancer Prev Res (Phila). 2011; 4: 1590-1598.
  • 271
    Demark-Wahnefried W, Polascik TJ, George SL, et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3577-3587.
  • 272
    Fang F, Kasperzyk JL, Shui I, et al. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One. 2011; 6: e18625.
  • 273
    Giovannucci E, Liu Y, Stampfer MJ, Willett WC. A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 203-210.
  • 274
    Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA, Henner WD. Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J Clin Oncol. 2003; 21: 123-128.
  • 275
    Beer TM, Lemmon D, Lowe BA, Henner WD. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma. Cancer. 2003; 97: 1217-1224.
  • 276
    The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994; 330: 1029-1035.
  • 277
    Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998; 90: 440-446.
  • 278
    Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009; 301: 39-51.
  • 279
    Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol. 1998; 81: 730-734.
  • 280
    Ma J, Li H, Giovannucci E, et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 2008; 9: 1039-1047.
  • 281
    Joshu CE, Mondul AM, Menke A, et al. Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res (Phila). 2011; 4: 544-551.
  • 282
    Thorsen L, Courneya KS, Stevinson C, Fossa SD. A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants. Support Care Cancer. 2008; 16: 987-997.
  • 283
    Segal RJ, Reid RD, Courneya KS, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009; 27: 344-351.
  • 284
    Mayne ST, Cartmel B, Baum M, et al. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer. Cancer Res. 2001; 61: 1457-1463.
  • 285
    Campbell BH, Spinelli K, Marbella AM, Myers KB, Kuhn JC, Layde PM. Aspiration, weight loss, and quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg. 2004; 130: 1100-1103.
  • 286
    Rademaker AW, Vonesh EF, Logemann JA, et al. Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout. Head Neck. 2003; 25: 1034-1041.
  • 287
    Gabor S, Renner H, Matzi V, et al. Early enteral feeding compared with parenteral nutrition after oesophageal or oesophagogastric resection and reconstruction. Br J Nutr. 2005; 93: 509-513.
  • 288
    McNeely ML, Parliament M, Courneya KS, et al. A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors. Head Neck. 2004; 26: 518-530.
  • 289
    McNeely ML, Parliament MB, Seikaly H, et al. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors: a randomized controlled trial. Cancer. 2008; 113: 214-222.
  • 290
    Rogers LQ, Courneya KS, Robbins KT, et al. Physical activity and quality of life in head and neck cancer survivors. Support Care Cancer. 2006; 14: 1012-1019.
  • 291
    Bauer J, Capra S, Battistutta D, Davidson W, Ash S; Cancer Cachexia Study Group. Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer. Clin Nutr. 2005; 24: 998-1004.
  • 292
    Barber MD. Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation. Nutrition. 2001; 17: 751-755.
  • 293
    Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol. 2003; 21: 129-134.
  • 294
    Moses AW, Slater C, Preston T, Barber MD, Fearon KC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004; 90: 996-1002.
  • 295
    Cawley MM, Benson LM. Current trends in managing oral mucositis. Clin J Oncol Nurs. 2005; 9: 584-592.
  • 296
    Willett WC. Micronutrients and cancer risk. Am J Clin Nutr. 1994; 59( suppl 5): 1162S-1165S.
  • 297
    Meyskens FL Jr, Szabo E. Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1366-1369.
  • 298
    NIH State-of-the-Science Panel. National Institutes of Health State-of-the-science conference statement: multivitamin/mineral supplements and chronic disease prevention. Ann Intern Med. 2006; 145: 364-371.
  • 299
    National Research Council. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Washington, DC: The National Academies Press; 2006.
  • 300
    Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park). 1999; 13: 1003-1008.
  • 301
    Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev. 1999; 4: 304-329.
  • 302
    D'Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin. 2005; 55: 319-321.
  • 303
    Kucuk O, Ottery F. Dietary supplements during cancer treatment. Oncology Issues. 2002; 17( suppl.): 22-30.
  • 304
    Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002; 137: 889-903.
  • 305
    Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev. 2001; 23: 72-81.
  • 306
    Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr. 1998; 68: 899-917.
  • 307
    Basch E, Bent S, Collins J, et al; Natural Standard Resource Collaboration. Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration. J Soc Integr Oncol. 2007; 5: 92-105.
  • 308
    Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005; 11: 3828-3835.
  • 309
    Kono S, Hirohata T. Nutrition and stomach cancer. Cancer Causes Control. 1996; 7: 41-55.
  • 310
    Sandhu MS, White IR, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev. 2001; 10: 439-446.
  • 311
    Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer. 2002; 98: 241-256.
  • 312
    Lin KY, Hu YT, Chang KJ, Lin HF, Tsauo JY. Effects of yoga on psychological health, quality of life, and physical health of patients with cancer: a meta-analysis [published online ahead of print March 9, 2011]. Evid Based Complement Alternat Med.
  • 313
    Messina MJ, Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001; 131( suppl 11): 3095S-3108S.
  • 314
    Kris-Etherton PM, Hecker KD, Bonanome A, et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002; 113( suppl 9B): 71S-88S.
  • 315
    Peeters PH, Keinan-Boker L, van der Schouw YT, Grobbee DE. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat. 2003; 77: 171-183.
  • 316
    Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1996; 5: 785-794.
  • 317
    Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR Jr. Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med. 2011; 171: 1625-1633.
  • 318
    International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Vol. 8. Fruits and Vegetables. Lyon, France: International Agency for Research on Cancer; 2003.
  • 319
    Duyff RL; American Dietetic Association. Complete Food and Nutrition Guide. 4th ed. Hoboken, NJ: John Wiley & Sons, Inc; 2012.
  • 320
    Craig WJ, Mangels AR; American Dietetic Association. Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc. 2009; 109: 1266-1282.
  • 321
    Sawka MN, Cheuvront SN, Carter R 3rd. Human water needs. Nutr Rev. 2005; 63( 6 pt 2): S30-S39.